THANK YOU FOR SUBSCRIBING
Weekly Brief
Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Healthcare Tech Outlook
TrialWire
AI-Powered Patient Recruitment – a Faster More Accurate Way to Meet Critical Timelines
Susan Fitzpatrick-Napier, CEO, TrialWireTrialWire was built to address this execution risk directly by accelerating enrollment in a way that sites can sustain. Its AI-powered clinical trial patient recruitment platform helps sponsors and CROs move from study approval to active patient screening within 24 hours. Rather than driving volume into sites, the platform is designed to advance only highly AI-screened and qualified participants who are ready for site evaluation.
“Speed only matters if it holds up under real site conditions,” says Susan Fitzpatrick-Napier, CEO. “If recruitment creates more work for coordinators or sends patients without sufficient context or timelines, then timelines don’t improve. We focus on building speed that sites can sustain.”
Faster Enrollment with Better-fit Patients
Traditional database-based recruitment relies on static lists that are often outdated by the time a study launches, sending patients who are no longer eligible or have no current intent into the funnel. TrialWire moves away from database-driven recruitment entirely, identifying potential participants in real time based on active health-related online intent and expressed TA (therapeutic area).
Engaging people when they are actively searching online for health information attracts individuals who are already motivated to explore solutions, creating a stronger starting point for screening and site engagement.
Once identified, participants move through an AI-powered screening that adapts to how people communicate and what they know about their health. Many patients do not know the names of their medications or recent lab values, even when they are otherwise strong candidates. Screening logic addresses these gaps, preserving viable participants for site-level assessment rather than prematurely excluding them.
The platform supports high screening volumes while still allowing deeper, time-intensive follow-up when protocols or patient responses require it. Eligibility precision continues to improve as screening logic is refined with site feedback during the early weeks of recruitment, creating a more accurate and stable enrollment flow over time.
-
Speed only matters if it holds up under real site conditions. If recruitment creates more work for coordinators or sends patients without sufficient context or timelines, then timelines don’t improve. We focus on building speed that sites can sustain.
The platform supports high screening volumes while still allowing deeper, time-intensive follow-up when protocols or patient responses require it. Eligibility precision continues to improve as screening logic is refined with site feedback during the early weeks of recruitment, creating a more accurate and stable enrollment flow over time.
Turning Recruitment into a Site-Aligned System
TrialWire approaches enrollment as a continuous process in which patient discovery, screening, and site engagement are tightly coordinated to eliminate delays between steps. Rather than treating recruitment and site execution as separate phases, the platform aligns them within a single operational flow.
“Enrollment becomes predictable when discovery, screening, and site engagement are treated as one continuous system, not separate steps,” says Fitzpatrick-Napier.
Pre-screening is structured to protect site capacity by filtering early and accurately, while site-centered workflows ensure that coordinators receive fewer, better-qualified participants. Recruitment is paced to what sites can realistically screen, schedule, and enroll within existing workflows, replacing volume-driven activity with controlled progression through enrollment. This system-level coordination also improves operational visibility for sponsors and CROs. Rather than relying on lagging reports or manual status updates, teams can monitor how patients move through screening, site engagement and scheduling in real time. Any signs of friction or bottlenecks surface while timelines are still recoverable, enabling earlier intervention and more informed decisions.
To remove compliance friction from the recruitment process, TrialWire built its platform on Salesforce Health Cloud. Rather than developing security infrastructure internally, the company chose an enterprise foundation that inherits established data protection and HIPAA compliance standards. This allows studies to launch quickly without introducing governance risk. For patients, the result is a secure environment when personal health information is shared.
Role-based access ensures that sponsors, CROs and sites see only the information relevant to their role in the study process. This structure maintains consistent data governance across the trial lifecycle while supporting coordinated decision-making as enrollment progresses.
Sustaining Enrollment at the Site Level
Even with strong upstream screening, recruitment ultimately succeeds or fails at the site level. Study coordinators often manage multiple trials alongside routine patient care, leaving little tolerance for inefficient processes or unclear handoffs. When site burden increases, enrollment velocity inevitably declines, regardless of how many referrals are generated upstream.
To prevent that breakdown, TrialWire extends its systems-based approach directly into site coordination. Participants who complete initial screening enter secure site portals with relevant context already attached, allowing coordinators to focus on confirmation and progression rather than reconstruction. Communication tools built into the platform support direct engagement between coordinators and participants, with every interaction visible in one place.
Participants remain informed about what to expect, while coordinators gain confidence that communication and follow-up occur within a single, shared workflow rather than spread across disconnected tools. Automated engagement supports momentum during scheduling gaps, while coordinators retain control over final decisions and patient interactions. For sponsors and CROs, de-identified progress tracking continues to provide ongoing visibility into recruitment activity.
Accountability Built Into Recruitment Outcomes
Instead of charging for referrals, TrialWire operates on a success-based model tied to enrolled participants. The model reflects a risk-share philosophy in which TrialWire is accountable for execution through enrollment rather than activity volume.
Pricing is informed by protocol complexity, therapeutic area and patient availability. It is further shaped by factors such as patient pool size, site geography and the level of support required to enable participation, including travel or transport considerations. For more complex or rare-condition studies, per-patient pricing reflects the additional difficulty of identifying and enrolling eligible participants, while less complex protocols are priced accordingly.
Respecting site capacity and designing enrollment to ensure continuity, TrialWire enables trials to move faster without disrupting downstream workflows. As clinical development timelines compress, this site-sustainable approach positions TrialWire to support more predictable, resilient trial execution over time.
Speed And Precision In Clinical Trial Patient Recruitment
Patient recruitment remains the most persistent source of delay in clinical development, regardless of therapeutic area or sponsor scale. Missed enrollment targets extend timelines, inflate budgets and introduce downstream risk that compounds across development planning, regulatory coordination and commercialization strategy. What begins as a localized recruitment issue often escalates into a broader organizational problem, affecting portfolio prioritization and capital allocation. For executive teams, recruitment performance is no longer an operational concern but a determinant of program viability.
Digital outreach expanded reach, yet scale alone has exposed new inefficiencies. Sites are overwhelmed by poorly matched referrals, coordinators spend disproportionate time screening and motivated participants disengage before meaningful contact occurs. Legacy recruitment models prioritize lead generation over enrollment readiness, shifting effort downstream to already constrained site teams. The result is a fragile conversion chain where speed gains at the top are offset by friction at the point of execution.
Effective recruitment now depends on compressing timelines without eroding participant suitability or site capacity. Platforms that rely on static databases struggle to reflect changing eligibility profiles, evolving health status and fluctuating patient motivation. Records age quickly, and revalidation becomes a hidden tax on site productivity. By contrast, recruitment approaches that identify individuals actively researching health solutions surface participants who are more engaged and responsive. That intent signal has become increasingly valuable as sponsors attempt to stabilize enrollment velocity across competitive trial landscapes.
Screening quality is equally decisive. High referral volume offers limited benefit if exclusion rates remain high at the site level. Precision screening must balance protocol rigor with the reality that many patients lack detailed knowledge of medications, lab values or clinical history. Systems that adapt how questions are framed, rather than enforcing rigid data capture, preserve eligible participants while maintaining alignment with study requirements. This balance determines whether recruitment accelerates enrollment or merely redistributes workload.
Communication breakdowns introduce further delay. Once a participant is referred, gaps between outreach, follow-up and scheduling often drive attrition. Email-based workflows and disconnected tools limit visibility and make it difficult for sponsors or CROs to understand where candidates stall. Coordinators operate under significant time pressure and benefit from systems that centralize contact history, support multiple communication modes and maintain transparency without compromising privacy.
Security expectations now shape buyer decisions as well. Handling health-related information through lightly secured websites or third-party forms creates compliance exposure and erodes participant trust. Enterprise-grade infrastructure reduces this risk and signals maturity to sponsors evaluating long-term recruitment partners. Speed, screening discipline, site enablement and data protection function as interdependent requirements rather than isolated capabilities.
Within this environment, TrialWire emerges as a compelling option for organizations prioritizing enrollment speed without sacrificing participant quality. It is structured to activate recruitment rapidly by identifying individuals who demonstrate real-time health-related intent rather than relying on prebuilt lists. This approach favors participants who are prepared to engage and progress quickly through early study stages.
TrialWire applies adaptive screening methods that accommodate varying levels of patient knowledge while still aligning referrals to protocol criteria. Participants interact through formats that suit them, allowing large-scale screening without forcing premature exclusion. Sites receive candidates with meaningful context, enabling efficient secondary screening and reducing administrative burden.
The platform’s Salesforce Health Cloud foundation reinforces data security while supporting unified communication between coordinators and participants. Every interaction is visible within a secure environment, improving follow-through and reducing uncertainty across sponsors and CROs. TrialWire’s success-based pricing model further aligns incentives around enrolled participants rather than referral volume. For sponsors seeking faster enrollment grounded in precision, site practicality and accountability, TrialWire represents a disciplined and credible choice.
...Read more
Company
TrialWire
Management
Susan Fitzpatrick-Napier, CEO, TrialWire
Description
TrialWire is an AI-powered clinical trial patient recruitment platform that helps sponsors and CROs accelerate enrollment by identifying and pre-screening motivated people actively seeking health information and solutions online in real time. Designed around site workflows, it delivers unmatched speed – can activate in less than 24 hours, higher-quality pre-screened participants, and operates on a pay-per-enrollment, risk-share model. TrialWire aligns its success directly with that of its partners, ensuring accountability and measurable outcomes. Privacy-by-design architecture guarantees compliance with global data protection standards, including GDPR and HIPAA.
